Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda

Kipp, Walter; Konde-Lule, Joseph; Rubaale, Tom; Okech-Ojony, Joa; Alibhai, Arif; Saunders, Duncan L.
January 2011
BMC International Health & Human Rights;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1
Academic Journal
Background: Improved availability of antiretroviral therapy in sub-Saharan Africa is intended to benefit all eligible HIV-infected patients; however in reality antiretroviral services are mainly offered in urban hospitals. Poor rural patients have difficulty accessing the drugs, making the provision of antiretroviral therapy inequitable. Initial tests of community-based treatment programs in Uganda suggest that home-based treatment of HIV/AIDS may equal hospital-based treatment; however the literature reveals limited experiences with such programs. The research: This intervention study aimed to; 1) assess the effectiveness of a rural community-based ART program in a subcounty (Rwimi) of Uganda; and 2) compare treatment outcomes and mortality in a rural community-based antiretroviral therapy program with a well-established hospital-based program. Ethics approvals were obtained in Canada and Uganda. Results and outcomes: Successful treatment outcomes after two years in both the community and hospital cohorts were high. All-cause mortality was similar in both cohorts. However, community-based patients were more likely to achieve viral suppression and had good adherence to treatment. The community-based program was slightly more cost-effective. Per capita costs in both settings were unsustainable, representing more than Uganda's Primary Health Care Services current expenditures per person per year for all health services. The unpaid community volunteers showed high participation and low attrition rates for the two years that this program was evaluated. Challenges and successes: Key successes of this study include the demonstration that antiretroviral therapy can be provided in a rural setting, the creation of a research infrastructure and culture within Kabarole's health system, and the establishment of a research collaboration capable of enriching the global health graduate program at the University of Alberta. Challenging questions about the long-term feasibility and sustainability of a community-based ARV program in Uganda still remain. The partnership: This project is a continuation of previous successful collaborations between the School of Public Health of Makerere University, the School of Public Health of University of Alberta, the Kabarole District Administration and the Kabarole Research and Resource Center.


Related Articles

  • Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy. Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI)...

  • Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. May, Margaret T; Hogg, Robert S; Justice, Amy C; Shepherd, Bryan E; Costagliola, Dominique; Ledergerber, Bruno; Thiébaut, Rodolphe; Gill, M John; Kirk, Ole; van Sighem, Ard; Saag, Michael S; Navarro, Gemma; Sobrino-Vegas, Paz; Lampe, Fiona; Ingle, Suzanne; Guest, Jodie L; Crane, Heidi M; D’Arminio Monforte, Antonella; Vehreschild, Jörg J; Sterne, Jonathan AC // International Journal of Epidemiology;Dec2012, Vol. 41 Issue 6, p1807 

    Background HIV cohort collaborations, which pool data from diverse patient cohorts, have provided key insights into outcomes of antiretroviral therapy (ART). However, the extent of, and reasons for, between-cohort heterogeneity in rates of AIDS and mortality are unclear.Methods We obtained data...

  • Results of a Community-Based Antiretroviral Treatment Program for HIV-1 Infection in Western Uganda. Kipp, Walter; Konde-Lule, Joseph; Saunders, L. Duncan; Alibhai, Arif; Houston, Stan; Rubaale, Tom; Senthilselvan, Ambikaipakan; Okech-Ojony, Joa; Kiweewa, Francis // Current HIV Research;Mar2010, Vol. 8 Issue 2, p179 

    Objective: To compare the treatment outcomes and mortality in a rural community-based ART (CBART) program with a hospital-based ART program in the same district. Methods: The study design was a non-randomized cohort study consisting of 185 persons living with HIV (PLWHIV) in the CBART cohort and...

  • When should antiretroviral therapy for HIV be started?  // Nursing Standard;1/31/2007, Vol. 21 Issue 21, p16 

    The article examines the right time to provide antiretroviral therapy for human immunodeficiency virus (HIV) patients in Great Britain. Treatment guidelines have cited from observational cohorts and have concluded that treatment should be first be considered as the CD4 count falls below 350x106/1.

  • Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART. Worodria, William; Massinga-Loembe, Marguerite; Mayanja-Kizza, Harriet; Namaganda, Jane; Kambugu, Andrew; Manabe, Yukari C.; Kestens, Luc; Colebunders, Robert // Clinical & Developmental Immunology;2011, p1 

    Commencement of antiretroviral treatment (ART) in severely immunosuppressed HIV-infected persons is associated with unmasking of subclinical disease. The subset of patients that are diagnosed with tuberculosis (TB) disease while on ART have been classified as ART-associated TB. Few studies have...

  • Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral Therapy. Griffin, Daniel O.; Metzger, Michael; Poeth, Kaitlin; Deng, Kathy; Dharsee, Arif; Rico, Juan Carlos; McGowan, Joseph // Open Forum Infectious Diseases;Fall2015, Vol. 2 Issue 4, p1 

    Human immunodeficiency virus (HIV)-1-infected individuals are affected by diseases at rates above those of their HIVnegative peers despite the increased life expectancy of the highly active antiretroviral therapy era. We followed a cohort of approximately 2000 HIV-1-infected patients for 5...

  • Enfuvirtide (T-20): A Novel Human Immunodeficiency Virus Type 1 Fusion Inhibitor. Cervia, Joseph S.; Smith, Miriam A. // Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1102 

    Describes the development of highly active antiretroviral therapy in reducing the progression of AIDS in HIV-infected patients in the U.S. Improvement of the life expectancy of patients; Conformational changes in the HIV envelope glycoprotein 41; Sensitivity of viral envelope to synthetic...

  • Optimizing Predictive Mining Techniques in HIV-Related Opportunistic Infections: Case for Botswana. Buthu'gwashe; Zhiyong Li; Kirui, Clement // International Journal of Computer Applications;Aug2013, Vol. 76 Issue 1-16, p1 

    Botswana was one of the first countries to establish a national Antiretroviral therapy (ART) programme in Africa. "Masa," a native word depicting "a new dawn," is the programme name. The AIDS epidemic has led to the emergence of several disease entities which in the pre-AIDS era seemed...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics